Logotype for Champions Oncology Inc

Champions Oncology (CSBR) investor relations material

Champions Oncology Q1 2026 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Champions Oncology Inc
Q1 2026 earnings summary15 Sep, 2025

Executive summary

  • Achieved $14.0 million in Q1 revenue, showing sequential growth but a slight year-over-year decline, with stability in core oncology and technology-enabled research services.

  • Growth was led by the TOS business and increasing contributions from the data platform, with ongoing expansion in radiopharmaceutical services and the Corellia drug discovery subsidiary.

  • Leadership transition with a new CEO, Rob Brainin, emphasizing continuity, strategic execution, and long-term growth.

  • Focus on expanding data-driven platforms, SaaS, and proprietary dataset licensing, with a robust pipeline at various discovery and validation stages.

  • Ongoing evaluation of strategic options for value creation and external funding for subsidiaries.

Financial highlights

  • Q1 revenue was $14.0 million, flat year-over-year but up from $12.4 million in Q4, with research services contributing $13.7 million and data business providing the remainder.

  • GAAP operating loss of $0.5 million and net loss attributable to common shares of $436,000, or $(0.03) per share, compared to net income of $1.3 million, or $0.10 per share, last year.

  • Adjusted EBITDA was $60,000, down from $2.0 million in the prior year.

  • Gross margin declined to 43% from 50% year-over-year due to higher outsourced lab costs.

  • Ended Q1 with $10.3 million in cash, up $0.5 million from year-end, and remained debt-free.

Outlook and guidance

  • Management anticipates sequential revenue growth and margin expansion as radiolabeling work shifts in-house and demand for proprietary data offerings increases.

  • Expects cash neutrality in Q2 and cash growth in the second half of fiscal 2026, with liquidity sufficient through at least October 2026.

  • Ongoing focus on expanding data licensing, SaaS, and R&D investment, with cautious optimism about improving market conditions.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Champions Oncology earnings date

Logotype for Champions Oncology Inc
Q2 202610 Dec, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Champions Oncology earnings date

Logotype for Champions Oncology Inc
Q2 202610 Dec, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Champions Oncology, Inc. is a technology-driven research organization that provides preclinical and clinical solutions to support drug development in the pharmaceutical and biotechnology industries. The company specializes in oncology-focused services, including patient-derived xenograft (PDX) models, biomarker discovery, and data analytics. The company is headquartered in Hackensack, New Jersey, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage